SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.70-0.1%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lamb who wrote (6418)12/3/1998 6:49:00 AM
From: James Baker  Read Replies (2) of 9523
 
Jim Lamb:Anybody else out there disappointed about the street's response to this new drug being approved. Minimal if any pop in the price of PFE. The share price is at the April level >>>>>>>>>

The market are taking a "sell on the news" attitude lately. This FDA approval was a long anticipated rubber stamp. There is the minor downside of no acute pain indication and no overwhelming safety statement vs NSAIDS.
Look at the chart of IMMUNEX (IMNX) after Enbrel got full FDA approval - it went thru immediate sell off BUT is is SOARING 2-3 wks later!
Stay tuned for PFE to do the same IF Searle/PFE is ready to roll Celebrex out the doors to the pharmacies once full FDA approval arrives.
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext